Global /Taiwan /Healthcare /Biotechnology /6876

LAUNXP Biomedical Co., Ltd.

6876

• TPEX: 6876 • Delayed

19.15TWD -3.3%

0.6053 USD

As of 21 June 2026, LAUNXP Biomedical Co., Ltd. has a market cap of $20.32M USD, ranking #36975 globally and #2233 in Taiwan. It ranks #3323 in the Healthcare sector, and #649 in the Biotechnology industry.

Global Rank

36975

Country Rank

2233

Sector Rank

3323

Industry Rank

649

Key Stats

Market Cap

$20.32MUSD

642.6M TWD

Company Profile

Country (HQ)

Taiwan

Sector

Healthcare

Industry

Biotechnology

CEO

Chiu-Heng Chen open_in_new

Founded

2015

Website

launxp.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-3.3%	-8.7%	-14%	-7.7%	-13%	-15%	15%	-24%	-24%

News

Markets

Exchange	Ticker	Price	Quotes
Taipei Exchange (TPEX) MIC: ROCO PRIMARY	6876 朗齊生物醫學股份有限公司 ISIN: TW0006876006 Shares Out.: Shares Outstanding: 69.218M¹ TV: TradingView: TPEX: 6876 SA: Stock Analysis: TPEX: 6876 YF: Yahoo Finance: 6876.TWO GF: Google Finance: TPEX: 6876 BA: Barron's: 6876 MS: Morningstar: ROCO: 6876	19.15 TWD	TV: TradingView: TPEX: 6876 SA: Stock Analysis: TPEX: 6876 YF: Yahoo Finance: 6876.TWO GF: Google Finance: TPEX: 6876 BA: Barron's: 6876 MS: Morningstar: ROCO: 6876

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About LAUNXP Biomedical Co., Ltd.

LAUNXP Biomedical Co., Ltd engages in the research and development of drugs for cancer patients. It develops various drugs, which are in preclinical stage, including LXP5948 for non-small cell lung cancer and Alzheimer's disease; LXP5268 for triple negative breast cancer; LXP5101 for pancreatic cancer; LXP1788 for gastrointestinal cancer; and Virus-like particles for cancer and genetic defect treatment. The company was founded in 2015 and is based in Taichung, Taiwan.

Similar Companies

Industry: Biotechnology (Taiwan)

Name	Market Cap (USD) diff.	PE	Country
Caliway Biopharmaceuticals Co., Ltd. TWSE: 6919	$5.46B 172.76B TWD 27K%	-	Taiwan
Pell Bio-Med Technology Co., Ltd. TWSE: 6949	$1.61B 50.93B TWD 8K%	-	Taiwan
Lin BioScience, Inc. TPEX: 6696	$1.08B 34.04B TWD 5K%	-	Taiwan
HanchorBio Inc. TWSE: 7827	$726.25M 22.97B TWD 3K%	-	Taiwan
HanchorBio Inc. TPEX: 7827	$600.25M 18.98B TWD 3K%	-	Taiwan
Locus Cell Co., Ltd. TPEX: 06891	$571.26M 18.06B TWD 3K%	-	Taiwan

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 898K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 787K%	19.0	United States
argenx SE EBR: ARGX	$47.43B 41.39B EUR 233K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.23B 68.19T KRW 218K%	35.5	South Korea
CSL Ltd. ASX: CSL	$42.27B 60.27B AUD 208K%	29.3	Australia
Lonza Group AG SIX: LONN	$41.88B 33.71B CHF 206K%	37.2	Switzerland

chevron_leftBack